NCT00817804

Brief Summary

The purpose of this study is to compare a new noninvasive ventilator to existing ventilators already used for patient care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

January 3, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 6, 2009

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2009

Completed
5 months until next milestone

Results Posted

Study results publicly available

August 12, 2009

Completed
Last Updated

August 19, 2009

Status Verified

August 1, 2009

Enrollment Period

2 months

First QC Date

January 3, 2009

Results QC Date

May 5, 2009

Last Update Submit

August 12, 2009

Conditions

Keywords

noninvasive ventilation

Outcome Measures

Primary Outcomes (1)

  • Breathing Comfort

    Comfort on visual analog scale 0 - 100, 0 is best

    30 minutes

Secondary Outcomes (5)

  • Saturation of Arterial Oxygen

    30 minutes

  • Respiratory Rate

    30 minutes

  • Minute Ventilation

    30 minutes

  • Heart Rate

    30 minutes

  • Blood Pressure

    30 minutes

Study Arms (2)

V60 then Conventional

EXPERIMENTAL

Study device first

Device: Use of the V60 Mask Ventilator

Conventional then V60

EXPERIMENTAL

Conventional device first

Device: Use of the V60 Mask Ventilator

Interventions

The V60 Mask Ventilator used to provide noninvasive ventilation. It is compared to the patient's conventional ventilator in a cross-over study. The ventilator settings can range from CPAP to Pressure Support ventilation with values of IPAP and EPAP to match the conventional ventilation on which the patient had been placed.

Also known as: V60 is the Philips V60 Ventilator
Conventional then V60V60 then Conventional

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age \> 7 years and \< 18 years
  • Weight \> 20 kg (44 lbs)
  • Respiratory failure or respiratory insufficiency
  • Ability to cooperate with the investigators
  • Designated adult able to provide Informed Consent

You may not qualify if:

  • An endotracheal tube or tracheostomy in place
  • Hemodynamically instability
  • Prolonged apnea
  • Inability to maintain the airway
  • A recent history of cardiac and or respiratory arrest
  • Acute hemorrhage
  • Multiple organ system failure
  • Undrained pneumothorax
  • High risk for aspiration
  • Metastatic or terminal cancer
  • Do-not-resuscitate orders
  • Inability to clear respiratory secretions
  • Inability to fit a mask
  • Facial surgery, trauma, or deformity
  • Upper gastrointestinal or airway surgery
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GF-221 Health Sciences Centre

Winnipeg, Manitoba, R3E 0Z3, Canada

Location

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Limitations and Caveats

Terminated before 20 patients enrolled

Results Point of Contact

Title
Adam Seiver
Organization
Respironics California

Study Officials

  • Steven Mink, MD

    University of Manitoba, Winnipeg, Manitoba, Canada

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

January 3, 2009

First Posted

January 6, 2009

Study Start

January 1, 2009

Primary Completion

March 1, 2009

Study Completion

March 1, 2009

Last Updated

August 19, 2009

Results First Posted

August 12, 2009

Record last verified: 2009-08

Locations